Literature DB >> 15083974

Adrenocorticotropic hormone levels in dogs with pituitary-dependent hyperadrenocorticism following trilostane therapy.

A L Witt1, R Neiger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15083974     DOI： 10.1136/vr.154.13.399

Source DB:  PubMed          Journal:  Vet Rec        ISSN： 0042-4900            Impact factor:   2.695


× No keyword cloud information.
  5 in total

1.  The influence of trilostane on steroid hormone metabolism in canine adrenal glands and corpora lutea-an in vitro study.

Authors:  C Ouschan; M Lepschy; F Zeugswetter; E Möstl
Journal:  Vet Res Commun       Date:  2011-11-25       Impact factor: 2.459

Review 2.  Update on the use of trilostane in dogs.

Authors:  Julie Lemetayer; Shauna Blois
Journal:  Can Vet J       Date:  2018-04       Impact factor: 1.008

3.  Carbenoxolone Disodium Treatment for Canine Pituitary-Dependent Hyperadrenocorticism.

Authors:  Takahiro Teshima; Hirotaka Matsumoto; Tomoko Okusa; Rion Uchiyama; Hidekazu Koyama
Journal:  PLoS One       Date:  2016-11-08       Impact factor: 3.240

4.  Comparison of methods to monitor dogs with hypercortisolism treated with trilostane.

Authors:  Stefania Golinelli; Viviani de Marco; Rodolfo Oliveira Leal; Andrea Barbarossa; Camilla Aniballi; Elisa Maietti; Antonio Maria Tardo; Sara Galac; Federico Fracassi
Journal:  J Vet Intern Med       Date:  2021-10-21       Impact factor: 3.333

5.  Effect of trilostane on hormone and serum electrolyte concentrations in dogs with pituitary-dependent hyperadrenocorticism.

Authors:  C Griebsch; C Lehnert; G J Williams; K Failing; R Neiger
Journal:  J Vet Intern Med       Date:  2013-12-16       Impact factor: 3.333
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.